Cardio Flashcards

(225 cards)

1
Q

What is acute heart failure?

A

Acute heart failure (AHF) refers to the rapid onset or worsening of the signs and symptoms of heart failure.

This is a life-threatening condition in which the heart does not pump enough blood to meet the body’s needs.

AHF may present as new-onset heart failure or as acute decompensation of chronic heart failure (CHF).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the 2 courses of pathology for AHF.

A
  1. Congestion in the pulmonary or systemic circulation. Pulmonary oedema develops when the left ventricle is unable to empty, which increases the hydrostatic pressure in pulmonary vasculature leading to pulmonary oedema and hypoxia. These patients are ‘WET’.
  2. Hypoperfusion of vital organs as the cardiac output is reduced. These patients are ‘COLD’.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name some causes of new-onset AHF

A

Acute myocardial dysfunction (e.g. ischaemia due to myocardial infarction)
Acute valve dysfunction
Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name some causes of acute decompensation of CHF

A

Infection
Acute myocardial dysfunction (e.g. ischaemia due to myocardial infarction)
Uncontrolled hypertension
Arrhythmias
Worsening chronic valve disease
Non-adherence with drugs/diet
Change in drug regimen
Withdrawal/reduction of heart failure medications inappropriately
Initiation/increase of rate-control medications inappropriately
Other medications: steroids, non-steroidal anti-inflammatories, pioglitazones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some typical symptoms of AHF ?

A

Dyspnoea
Reduced exercise tolerance (classify using the New York Heart Association classification)3
Ankle swelling (clarify how high and whether this is progressing)
Fatigue
Pink frothy sputum
Orthopnoea (ask about the number of pillows used)
Paroxysmal nocturnal dyspnoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Signs of Pulmonary or Systemic Congestion seen in AHF.

A

Fine basal crackles (bilateral)
Peripheral oedema (bilateral)
Dull percussion at the lung bases
Raised jugular venous pressure (JVP)
Hepatomegaly
Gallop rhythm (S3 or S4 heart sounds)
Murmur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Signs of Hypoperfusion seen in AHF

A

Hypoxia
Tachypnoea and accessory muscle use
Tachycardia
Cyanosis
Cold, pale, and sweaty peripheries
Oliguria
Confusion/agitation
Syncope/pre-syncope
Narrow pulse pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Differential Dx for AHF

A

Asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and pulmonary oedema due to AHF can be difficult to differentiate, especially where they may coexist in older patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ix for AHF

A

Vital Signs
ECG
BNP
ABG
CXR
Echo
Lung USS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What may vital signs show in AHF?

A

may show hypoxia (often SpO2 < 90%), tachycardia, and tachypnoea. The systolic blood pressure may be normal, elevated, or reduced (hypotension is associated with cardiogenic shock and poor prognosis). The pulse pressure may be narrow (<25% of the sBP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What may ECG show in AHF?

A

the ECG is rarely normal. Abnormalities (e.g. signs of ischaemia or arrhythmias) are very common in AHF and an alternative diagnosis should be considered if the ECG is completely normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is BNP?

A

B‑type natriuretic peptide (BNP): BNP is a sensitive but non-specific marker of heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What may BNP show in AHF?

A

AHF is unlikely and can be ruled out if:
BNP is less than 100 ng/litre
NT‑proBNP is less than 300 ng/litre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What may an ABG show in AHF ?

A

often shows type 1 respiratory failure, or type 2 respiratory failure in those with pre-existing chronic lung conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What Ix are used to R/O other causes/pathologies in suspected AHF?

A

Baseline Bloods : FBC, U&E, Coagulation, CRP –> anaemia?
Cardiac Troponin –> MI?
TSH –> abnormatlities can precipitatet AHF
D-dimer–> PE suspected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What may CXR show in AHF?

A

abnormalities are present in up to 80% of patients in AHF. If the chest X-ray is normal, consider alternative diagnoses such as a pulmonary embolism or exacerbation of asthma/COPD. It can help exclude other causes of dyspnoea such as pneumonia or pneumothorax.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What may an Echo show in AHF?

A

should be performed early in those with suspected AHF, especially if cardiogenic shock or life-threatening cardiac abnormalities are present. The echocardiogram assesses:
Biventricular systolic and diastolic function for ventricular dilation, reduced ejection fraction, ventricular hypertrophy and poor contractility
Valve disease
Ventricular wall rupture
Pericardial effusion
Intracardiac shunts: the presence of a dilated inferior vena cava with reduced respiratory variation is indicative of high venous pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What may a Lung USS show in AHF?

A

may reveal extracardiac pathology such as pulmonary embolism or B-lines (consistent with interstitial oedema in pulmonary oedema)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chest X-ray findings in AHF

A

A mnemonic to remember chest x-ray findings in heart failure is ABCDE:

A: alveolar oedema (perihilar/bat-wing opacification)
B: Kerley B lines (interstitial oedema)
C: cardiomegaly (cardiothoracic ratio >50%) – may be difficult to assess on an AP film
D: dilated upper lobe vessels
E: effusions (i.e. pleural effusions – blunted costophrenic angles with meniscus sign)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Identify conditions early on which may have precipitated AHF and treat these urgently. Look out for CHAMP conditions:

A

Acute coronary syndrome (ACS)
Hypertensive crisis
Arrhythmias, e.g. atrial fibrillation, ventricular tachycardia, bradyarrhythmia
Mechanical problems, e.g. myocardial rupture as a complication of ACS, valve dysfunction
Pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acute Medical Management of AHF

A

Oxygen
Loop Diuretics
Nitrates
NIV
Tx for cardiogenic shock: inotopes + vasopressors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How do loop diuretics help in the acute management of AHF?

A

Diuretics increase sodium excretion causing diuresis and decrease afterload. All ‘WET’ patients will require diuretics as the cornerstone of their management.
Administer 40 milligrams furosemide intravenously initially to improve symptoms of congestion fluid overload.
Patients with chronic kidney disease and those already on oral diuretics will need a greater dose. Monitor renal function and urine output to titrate dose according to clinical response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How do Nitrates help in the acute management of AHF?

A

Nitrates (sublingual glyceryl trinitrate or intravenous nitrates) are the second most used agents in AHF used for ‘WET’ patients. Do not use nitrates in those with SBP <90mmHg or aortic stenosis, who rely on sufficient preload to overcome their pressure gradient.
Nitrates cause venous and/or arterial dilation to reduce preload and/or afterload. They are given to patients with concomitant myocardial ischaemia or hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do NIV help in the acute management of AHF?

A

CPAP or BiPAP are used for those with cardiogenic pulmonary oedema, dyspnoea, and
NIV improves ventilation to reduce respiratory distress and drives fluid out of alveoli and into vasculature in those whose respiratory failure is not controlled with oxygen therapy given via a face mask.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How do you control cardiogenic shock in AHF?
Some ‘COLD’ patients whose AHF has led to a potentially reversible cardiogenic shock may present with haemodynamic instability (systolic blood pressure <90mmHg). These patients require early expert help. Specialists may consider inotropes (e.g. dobutamine) to increase cardiac output and peripheral perfusion, and vasopressors (e.g. adrenaline) to increase blood pressure and vital organ perfusion. The use of these drugs is associated with poorer outcomes.
26
Long term management of AHF aims to ____
Increase CO by optimising preload and contractility whilst decreasing afterload.
27
What is included in the long term management of AHF?
Before discharge, consider offering patients with reduced ejection fraction (LVEF <40%) heart failure a selection of treatments: - Diuretics - ACE inhibitors / ARBs - Beta Blockers - Aldosterone antagonist
28
What do ACEi do for the long term management of AHF?
ACEi/ARBs decrease activation of the renin-angiotensin-aldosterone system (RAAS). Contraindications include a history of angioedema, bilateral renal artery stenosis, hyperkalaemia (>5 mmol/L), severe renal impairment (serum creatinine >220 μmol/L) and severe aortic stenosis.
29
What do BBs do for the long term management of AHF?
Begin therapy once established on a diuretic and ACEi/ARB, and when BP and congestion are controlled. Beta-blockers decrease heart rate, myocardium oxygen demand and RAAS activation. Contraindications include asthma, 2nd or 3rd-degree atrioventricular block, sick sinus syndrome and sinus bradycardia. ‘Start low and go slow’
30
What do Aldosterone Antagonsits do for the long term management of AHF?
Antagonise aldosterone increasing ­sodium excretion causing diuresis and decreased afterload.
31
Which medication can be used for patients who cannot have a beta-blocker or who are on the maximum dose already, if they are in sinus rhythm with a heart rate >75? (AHF longterm management)
Ivabradine
32
Which medication can be used for patients who decompensate on an ACEi/ARB ? (AHF longterm management)
Sacubitril valsartan
33
Which medication can be used for patients who cannot tolerate an ACEi/ARB, or who are on the maximum dose ? (AHF longterm management)
Hydralazine and nitrate:
34
Which medication can be used for patients with atrial fibrillation and uncontrolled tachycardia despite a beta-blocker? (AHF longterm management)
Digoxin
35
Complications of AHF
About 40% of people admitted to hospital with heart failure die or are readmitted within 1 year.9 AHF may cause arrhythmias, particularly atrial fibrillation. There is an increased risk of stroke and other thromboembolic diseases following an episode of AHF.
36
What is chronic heart failure (CHF) ?
Chronic heart failure (CHF) is a clinical syndrome involving reduced cardiac output because of impaired cardiac contraction. Typical clinical symptoms of CHF include shortness of breath, fatigue and ankle swelling
37
Causes of Heart failure
The most common causes of heart failure in the UK are coronary heart disease (myocardial infarction), atrial fibrillation, valvular heart disease and hypertension. Other causes of heart failure include: Endocrine disease: hypothyroidism, hyperthyroidism, diabetes, adrenal insufficiency, Cushing’s syndrome Medications: calcium antagonists, anti-arrhythmics, cytotoxic medication, beta-blockers. High-output cardiac failure occurs in states where demand exceeds normal cardiac output such as pregnancy, anaemia and sepsis.
38
Acronymn to rememeber causes of HF
The acronym HIGH-VIS is useful to remember some of the causes of CHF: Hypertension (common cause) Infection/immune: viral (e.g. HIV), bacterial (e.g. sepsis), autoimmune (e.g. lupus, rheumatoid arthritis) Genetic: hypertrophic obstructive cardiomyopathy (HOCM), dilated cardiomyopathy (DCM) Heart attack: ischaemic heart disease (common cause) Volume overload: renal failure, nephrotic syndrome, hepatic failure Infiltration: sarcoidosis, amyloidosis, haemochromatosis Structural: valvular heart disease, septal defects
39
Typical symptoms of CHF
Dyspnoea on exertion Fatigue limiting exercise tolerance Orthopnoea: the patient may be using several pillows to reduce this symptom. Paroxysmal nocturnal dyspnoea (PND): attacks of severe shortness of breath in the night that are relieved by sitting up (pathognomonic for CHF). Nocturnal cough with or without the characteristic ‘pink frothy sputum’. Pre-syncope/syncope Reduced appetite
40
What is paroxysmal nocturnal dyspnoea?
Paroxysmal nocturnal dyspnoea (PND) describes the experience that patients have of suddenly waking at night with a severe attack of shortness of breath, cough and wheeze. They may describe having to sit on the side of the bed or walk around the room, gasping for breath. They may feel suffocated and want to open a window to get fresh air. Symptoms improve over several minutes. There are a few proposed mechanisms to explain paroxysmal nocturnal dyspnoea. Firstly, fluid settles across a large surface area of the lungs as they lie flat to sleep, causing breathlessness. As they stand up, the fluid sinks to the lung bases, and the upper lung areas function more effectively. Secondly, during sleep, the respiratory centre in the brain becomes less responsive, so the respiratory rate and effort do not increase in response to reduced oxygen saturation like they would when awake. This allows the person to develop more significant pulmonary congestion and hypoxia before they wake up feeling very unwell. Thirdly, there is less adrenalin circulating during sleep. Less adrenalin means the myocardium is more relaxed, reducing cardiac output.
41
Signs of CHF
Clinical findings on cardiovascular examination may include: Tachycardia at rest Hypotension Narrow pulse pressure Raised jugular venous pressure Displaced apex beat (due to left ventricular dilatation) Right ventricular heave Gallop rhythm on auscultation (pathognomic for CHF) Murmurs associated with valvular heart disease (e.g. an ejection systolic murmur in aortic stenosis) Pedal and ankle oedema Clinical findings on respiratory examination may include: Tachypnoea Bibasal end-inspiratory crackles and wheeze on auscultation of the lung fields Reduced air entry on auscultation with stony dullness on percussion (pleural effusion) Clinical findings on abdominal examination may include: Hepatomegaly Ascites
42
Ix of CHF
ECG + urinalysis + Bloods + Echo + CXR + Cardiac MRI
43
What may ECG show in CHF?
should be performed on all patients with suspected heart failure. An ECG may identify evidence of previous myocardial infarction (e.g. ‘Q’ waves) or arrhythmias (AV block or atrial fibrillation). A normal ECG makes heart failure unlikely
44
What may urinalysis show in CHF?
may show glycosuria (diabetes) or proteinuria (renal disease)
45
ECG associated with heart failure include:
Tachycardia Atrial fibrillation (due to enlarged atria) Left-axis deviation (due to left ventricular hypertrophy) P wave abnormalities (e.g. P.mitrale/P.pulmonale due to atrial enlargement) Prolonged PR interval (due to AV block) Wide QRS complexes (due to ventricular dyssynchrony)
46
Bloods Ix for CHF
FBC: anaemia U&Es: renal failure, electrolyte abnormalities due to fluid overload (e.g. hyponatraemia) LFTs: hepatic congestion Troponin: if considering recent myocardial infarction Lipids/HbA1c: ischaemic risk profile TFTs: hyperthyroidism/hypothyroidism Cardiomyopathy screen N-terminal pro-B-type natriuretic peptide
47
What is a cardiomyopathy screen ?
Serum iron and copper studies (to rule out haemochromatosis and Wilson’s disease) Rheumatoid factor, ANCA/ANA, ENA, dsDNA (to rule out autoimmune disease) Serum ACE (to rule out sarcoidosis) Serum-free light chains (to rule out amyloidosis)
48
NT-proBNP
N-terminal pro-B-type natriuretic peptide (NT-proBNP) should be measured in all patients presenting with symptoms and clinical signs of heart failure to inform the type and urgency of further investigations such as echocardiography: NT-proBNP level >2000 ng/L – refer urgently for specialist assessment and transthoracic echocardiography within 2 weeks NT-proBNP level 400-2000ng/L – refer routinely for specialist assessment and transthoracic echocardiography within 6 weeks NT-proBNP level <400 ng/L – heart failure unlikely
49
Other conditions in which NT-proBNP may be raised include:
Left ventricular hypertrophy Tachycardia Liver cirrhosis Diabetes Acute or chronic renal disease
50
What is the gold standard Ix for CHF?
Cardiac MRI is the gold standard investigation for assessing ventricular mass, volume and wall motion. It can also be used with contrast to identify infiltration (e.g. amyloidosis), inflammation (e.g. myocarditis) or scarring (e.g. myocardial infarction). It is typically used when echocardiography has provided inadequate views
51
Structural classification of CHF
Chronic heart failure can be classified structurally based on left ventricular ejection fraction (LVEF). LVEF is the percentage of blood that enters the left ventricle in diastole that is subsequently pumped out in systole. LVEF is usually measured using transthoracic echocardiography, however, MRI, nuclear medicine scans and transoesophageal echocardiography can also be used
52
Symptomatic/ functional classification of CHF
The New York Heart Association’s (NYHA) classification system relies on patient symptoms and level of function:3 Class I: no symptoms during ordinary physical activity Class II: slight limitation of physical activity by symptoms Class III: less than ordinary activity leads to symptoms Class IV: inability to carry out any activity without symptoms
53
Lifestyle Managment of CHF
Fluid and salt restriction Regular exercise Smoking cessation Reduced alcohol intake
54
Medication review for CHF - which meds can damage more CHF?
Calcium channel blockers (e.g. verapamil, diltiazem) Tricyclic antidepressants Lithium NSAIDs and COX-2 inhibitors Corticosteroids QT-prolonging medications
55
All patients with chronic heart failure require monitoring of:
Functional capacity, fluid status, cardiac rhythm, cognitive status and nutritional status Renal function The frequency of monitoring depends on the patient’s clinical condition.
56
The first-line medical treatment of chronic heart failure can be remembered with the “ABAL” mnemonic:
A – ACE inhibitor (e.g., ramipril) titrated as high as tolerated B – Beta blocker (e.g., bisoprolol) titrated as high as tolerated A – Aldosterone antagonist when symptoms are not controlled with A and B (e.g., spironolactone or eplerenone) L – Loop diuretics (e.g., furosemide or bumetanide)
57
Pharmalogical Management of CHF
Diuretics ACEi Beta Blockers ARBs Mineralocorticoid/aldosterone receptor antagonists (MRAs) Sodium-glucose cotransporter-2 (SGLT2) inhibitors
58
What is the purpose of Diuretics in the management of CHF?
Diuretics should be prescribed to relieve symptoms of fluid overload (e.g. shortness of breath, peripheral oedema). Diuretics (e.g. furosemide) work by increasing sodium excretion via diuresis, ultimately reducing cardiac afterload. Doses should be titrated according to clinical response and renal function should be closely monitored.
59
What is the purpose of ACEi in the management of CHF?
All patients with CHF and a reduced ejection fraction (≤40%) should be commenced on an ACE inhibitor unless contraindicated. ACE inhibitors have been shown to improve ventricular function and reduce mortality. U&Es should be checked prior to starting treatment and then after 1-2 weeks of treatment.
60
Contraindications to ACEi
include a history of angioedema, bilateral renal artery stenosis, hyperkalaemia (>5 mmol/L), severe renal impairment (serum creatinine >220 μmol/L) and severe aortic stenosis.
61
What is the purpose of Beta Blockers in the management of CHF?
Beta-blockers (e.g. bisoprolol) should be prescribed for all patients with symptomatic heart failure and reduced LVEF (≤40%) unless contraindicated. Beta-blockers decrease heart rate, myocardial oxygen demand and RAAS activation. Blood pressure and heart rate need to be monitored carefully when adjusting doses.
62
Contraindications of BBs
include asthma, 2nd or 3rd degree AV block, sick sinus syndrome and sinus bradycardia.
63
What is the purpose of ARBs in the management of CHF?
If a patient is unable to tolerate an ACE inhibitor (usually due to persistent cough) an ARB (e.g. candesartan) should be prescribed as an alternative. Patients must have normal serum potassium and adequate renal function to commence an ARB.
64
What is the purpose of MRAs in the management of CHF?
A low-dose aldosterone antagonist (e.g. spironolactone or eplerenone) should also be prescribed if a patient continues to have symptoms of heart failure despite diuretics, ACE inhibitors and beta-blockers. MRAs antagonise aldosterone, increasing sodium excretion via diuresis, ultimately decreasing cardiac afterload.
65
What is the purpose of SGLT2 inhibitors in the management of CHF?
SGLT2 inhibitors (e.g. dapagliflozin) can be used as add-on therapy in patients with a reduced LVEF (<40%). Dapagliflozin has been shown to reduce the risk of cardiovascular events and hospital admission. This benefit occurs regardless of the patient’s glycaemic control.
66
What is Ivabradine + what does it do?
Ivabradine inhibits the sinoatrial node, slowing the heart rate of patients in sinus rhythm, increasing stroke volume whilst preserving myocardial contractility. It has been shown to reduce cardiovascular death or hospitalisation for heart failure by 18%.
67
Procedural and Surgical Interventions for CHF
Surgical procedures may be used to treat underlying valvular heart disease. Implantable cardioverter defibrillators continually monitor the heart and apply a defibrillator shock to cardiovert the patient back into sinus rhythm if they identify a shockable arrhythmia. These are used in patients who previously had ventricular tachycardia or ventricular fibrillation. Cardiac resynchronisation therapy (CRT) may be used in severe heart failure, with an ejection fraction of less than 35%. CRT involves biventricular (triple chamber) pacemakers, with leads in the right atrium, right ventricle and left ventricle. The objective is to synchronise the contractions in these chambers to optimise heart function. A heart transplant may be considered in suitable patients with severe disease.
68
Complications of CHF include:
Arrhythmias: atrial fibrillation and ventricular arrhythmias Depression and impaired quality of life Loss of muscle mass Sudden cardiac death Prognosis is poor overall, with approximately 50% of people with heart failure dying within five years of diagnosis.7
69
Left sided heart failure
HF-rEF and HF-pEF typically develop left-sided heart failure. This may be due to increased left ventricular afterload (e.g. arterial hypertension or aortic stenosis) or increased left ventricular preload (e.g. aortic regurgitation resulting in backflow to the left ventricle).
70
Right sided heart failure
Right-sided heart failure is caused by either increased right ventricular afterload (e.g. pulmonary hypertension) or increased right ventricular preload (e.g. tricuspid regurgitation).
71
Left ventricular failure typically results in:
pulmonary oedema dyspnoea orthopnoea paroxysmal nocturnal dyspnoea bibasal fine crackles
72
Right ventricular failure typically results in:
peripheral oedema ankle/sacral oedema raised jugular venous pressure hepatomegaly weight gain due to fluid retention anorexia ('cardiac cachexia')
73
Causes of Increased BNP levels
Left ventricular hypertrophy Ischaemia Tachycardia Right ventricular overload Hypoxaemia (including pulmonary embolism) GFR < 60 ml/min Sepsis COPD Diabetes Age > 70 Liver cirrhosis
74
Causes of Decreased BNP levels
Obesity Diuretics ACE inhibitors Beta-blockers Angiotensin 2 receptor blockers Aldosterone antagonists
75
What are arrthymias ?
Arrhythmias are abnormal heart rhythms. They result from an interruption to the normal electrical signals that coordinate the contraction of the heart muscle.
76
Shockable rhythms:
Ventricular tachycardia Ventricular fibrillation
77
Non-shockable rhythms:
Pulseless electrical activity (all electrical activity except VF/VT, including sinus rhythm without a pulse) Asystole (no significant electrical activity)
78
Narrow complex tachycardia
refers to a fast heart rate with a QRS complex duration < 0.12 seconds (3 small squares)
79
There are four main differentials of a narrow complex tachycardia:
Sinus tachycardia (treatment focuses on the underlying cause) Supraventricular tachycardia (treated with vagal manoeuvres and adenosine) Atrial fibrillation (treated with rate control or rhythm control) Atrial flutter (treated with rate control or rhythm control, similar to atrial fibrillation)
80
Sinus tachycardia
Sinus tachycardia will take the normal P wave, QRS complex and T wave pattern. Sinus tachycardia is not an arrhythmia and is usually a response to an underlying cause, such as sepsis or pain.
81
Supraventricular tachycardia (SVT)
looks like a QRS complex followed immediately by a T wave, then a QRS complex, then a T wave, and so on. There are P waves, but they are often buried in the T waves, so you cannot see them. It can be distinguished from atrial fibrillation by the regular rhythm and atrial flutter by the absence of a saw-tooth pattern.
82
How do you distinguish SVT from sinus tachycardia ?
It can be tricky to distinguish SVT from sinus tachycardia. SVT has an abrupt onset and a very regular pattern without variability. Sinus tachycardia has a more gradual onset and more variability in the rate. The history is also important, where sinus tachycardia usually has an explanation (e.g., pain or fever), while SVT can appear at rest with no apparent cause.
83
Atrial fibrillation
absent P waves and an irregularly irregular ventricular rhythm.
84
Atrial Flutter
the atrial rate is usually around 300 beats per minute and gives a saw-tooth pattern on the ECG. A QRS complex occurs at regular intervals depending on how often there is conduction from the atria. This often results in two atrial contractions for every one ventricular contraction, giving a ventricular rate of 150 beats per minute. Atrial flutter gives a sawtooth appearance on the ECG, with repeated P wave occurring at around 300 per minute, with a narrow complex tachycardia. There may be 3:1, 4:1 or variable conduction ratios.
85
What are the life-threatening features of arrythmias?
loss of consciousness (syncope), heart muscle ischaemia (e.g., chest pain), shock or severe heart failure
86
Treatment of life-threatening arrythmia
synchronised DC cardioversion under sedation or general anaesthesia. Intravenous amiodarone is added if initial DC shocks are unsuccessful.
87
Broad complex tachycardia
refers to a fast heart rate with a QRS complex duration of more than 0.12 seconds or 3 small squares on an ECG.
88
The resuscitation guidelines break down broad complex tachycardia into:
Ventricular tachycardia or unclear cause (treated with IV amiodarone) Polymorphic ventricular tachycardia, such as torsades de pointes (treated with IV magnesium) Atrial fibrillation with bundle branch block (treated as AF) Supraventricular tachycardia with bundle branch block (treated as SVT)
89
Pathophysiology of atrial flutter
Normally the electrical signal passes through the atria once, stimulating a contraction, then disappears through the atrioventricular node into the ventricles. Atrial flutter is caused by a re-entrant rhythm in either atrium. The electrical signal re-circulates in a self-perpetuating loop due to an extra electrical pathway in the atria. The signal goes round and round the atrium without interruption. The atrial rate is usually around 300 beats per minute. The signal does not usually enter the ventricles on every lap due to the long refractory period of the atrioventricular node. This often results in two atrial contractions for every one ventricular contraction (2:1 conduction), giving a ventricular rate of 150 beats per minute.
90
Treatment of atrial flutter
Treatment is similar to atrial fibrillation, including anticoagulation based on the CHA2DS2-VASc score. Radiofrequency ablation of the re-entrant rhythm can be a permanent solution.
91
QT interval
from the start of the QRS complex to the end of the T wave.
92
Parametes of Prolonged QT Interval
More than 440 milliseconds in men More than 460 milliseconds in women
93
Pathophysiology of Prolonged QT interval
A prolonged QT interval represents prolonged repolarisation of the heart muscle cells (myocytes) after a contraction. Depolarisation is the electrical process that leads to heart contraction. Repolarisation is a recovery period before the muscle cells are ready to depolarise again. Waiting a long time for repolarisation can result in spontaneous depolarisation in some muscle cells. These abnormal spontaneous depolarisations before repolarisation are known as afterdepolarisations. These afterdepolarisations spread throughout the ventricles, causing a contraction before proper repolarisation. When this leads to recurrent contractions without normal repolarisation, it is called torsades de pointes.
94
Torsades de pointes
Torsades de pointes is a type of polymorphic ventricular tachycardia. It translates from French as “twisting of the spikes”, describing the ECG characteristics. On an ECG, it looks like standard ventricular tachycardia but with the appearance that the QRS complex is twisting around the baseline. The height of the QRS complexes gets progressively smaller, then larger, then smaller, and so on. Torsades de pointes will terminate spontaneously and revert to sinus rhythm or progress to ventricular tachycardia. Ventricular tachycardia can lead to cardiac arrest.
95
Causes of prolonged QT include:
Long QT syndrome (an inherited condition) Medications, such as antipsychotics, citalopram, flecainide, sotalol, amiodarone and macrolide antibiotics Electrolyte imbalances, such as hypokalaemia, hypomagnesaemia and hypocalcaemia
96
Management of a prolonged QT interval involves:
Stopping and avoiding medications that prolong the QT interval Correcting electrolyte disturbances Beta blockers (not sotalol) Pacemakers or implantable cardioverter defibrillators
97
Acute management of torsades de pointes involves:
Correcting the underlying cause (e.g., electrolyte disturbances or medications) Magnesium infusion (even if they have normal serum magnesium) Defibrillation if ventricular tachycardia occurs
98
Ventricular ectopics
premature ventricular beats caused by random electrical discharges outside the atria. Patients often present complaining of random extra or missed beats. They are relatively common at all ages and in healthy patients. However, they are more common in patients with pre-existing heart conditions (e.g., ischaemic heart disease or heart failure).
99
Appearance of Ventricular Ectopics
appear as isolated, random, abnormal, broad QRS complexes on an otherwise normal ECG.
100
Bigeminy
Bigeminy refers to when every other beat is a ventricular ectopic. The ECG shows a normal beat (with a P wave, QRS complex and T wave), followed immediately by an ectopic beat, then a normal beat, then an ectopic, and so on.
101
Management of Ventricular Ectopics
Reassurance and no treatment in otherwise healthy people with infrequent ectopics Seeking specialist advice in patients with underlying heart disease, frequent or concerning symptoms (e.g., chest pain or syncope), or a family history of heart disease or sudden death Beta blockers are sometimes used to manage symptoms
102
First Degree Heart Block
First-degree heart block occurs where there is delayed conduction through the atrioventricular node. Despite this, every atrial impulse leads to a ventricular contraction, meaning every P wave is followed by a QRS complex. On an ECG, first-degree heart block presents as a PR interval greater than 0.2 seconds (5 small or 1 big square).
103
Second Degree Heart Block
Second-degree heart block is where some atrial impulses do not make it through the atrioventricular node to the ventricles. There are instances where P waves are not followed by QRS complexes. There are two types of second-degree heart block: Mobitz type 1 (Wenckebach phenomenon) Mobitz type 2 There is usually a set ratio of P waves to QRS complexes, for example, three P waves for each QRS complex (3:1 block). A 2:1 block is where there are two P waves for each QRS complex. Every other P wave does not stimulate a QRS complex. It can be difficult to tell whether this is caused by Mobitz type 1 or Mobitz type 2.
104
Mobitz Type 1
Mobitz type 1 (Wenckebach phenomenon) is where the conduction through the atrioventricular node takes progressively longer until it finally fails, after which it resets, and the cycle restarts. On an ECG, there is an increasing PR interval until a P wave is not followed by a QRS complex. The PR interval then returns to normal, and the cycle repeats itself.
105
Mobitz Type 1
Mobitz type 2 is where there is intermittent failure of conduction through the atrioventricular node, with an absence of QRS complexes following P waves. The PR interval remains normal. There is a risk of asystole with Mobitz type 2.
106
3rd Degree Heart Block
Third-degree heart block is also called complete heart block. There is no observable relationship between the P waves and QRS complexes. There is a significant risk of asystole with third-degree heart block.
107
What is bradycardia
Bradycardia refers to a slow heart rate, typically less than 60 beats per minute. A heart rate under 60 can be normal in healthy fit patients without causing any symptoms.
108
Causes of Bradycardia
Medications (e.g., beta blockers) Heart block Sick sinus syndrome
109
Sick sinus syndrome
Sick sinus syndrome encompasses many conditions that cause dysfunction in the sinoatrial node. It is often caused by idiopathic degenerative fibrosis of the sinoatrial node. It can result in sinus bradycardia, sinus arrhythmias and prolonged pauses.
110
Asystole
refers to the absence of electrical activity in the heart (resulting in cardiac arrest).
111
There is a risk of asystole in:
Mobitz type 2 Third-degree heart block (complete heart block) Previous asystole Ventricular pauses longer than 3 seconds
112
Management of unstable patients and those at risk of asystole involves:
Intravenous atropine (first line) Inotropes (e.g., isoprenaline or adrenaline) Temporary cardiac pacing Permanent implantable pacemaker, when available
113
Options for temporary cardiac pacing are:
Transcutaneous pacing, using pads on the patient’s chest Transvenous pacing, using a catheter, fed through the venous system to stimulate the heart directly
114
Atropine
antimuscarinic medication and works by inhibiting the parasympathetic nervous system.
115
SE of atropine
Inhibiting the parasympathetic nervous system leads to side effects of pupil dilation, dry mouth, urinary retention and constipation.
116
NICE definition of Hypertension
The NICE guidelines on hypertension (updated 2022) suggest a diagnosis of hypertension with a blood pressure above 140/90 in the clinical setting, confirmed with ambulatory or home readings above 135/85.
117
Essential hypertension accounts for __% of hypertension
90
118
What is essential HTN?
also known as primary hypertension. It means a high blood pressure has developed on its own and does not have a secondary cause.
119
Secondary causes of HTN
can be remembered with the “ROPED” mnemonic: R – Renal disease O – Obesity P – Pregnancy-induced hypertension or pre-eclampsia E – Endocrine D – Drugs (e.g., alcohol, steroids, NSAIDs, oestrogen and liquorice)
120
What is the most common cause of secondary HTN?
Renal disease ; When the blood pressure is very high or does not respond to treatment, consider renal artery stenosis. Renal artery stenosis can be diagnosed with duplex ultrasound or an MR or CT angiogram.
121
Which endocrine conditions can cause HTN?
Most endocrine conditions can cause hypertension. Hyperaldosteronism (Conn’s syndrome) is an important cause and may be present in 5-10% of patients with hypertension.
122
Examples of Kidney diseases that cause HTN
Glomerulonephritis Chronic pyelonephritis Diabetic nephropathy Renal cell carcinoma Polycystic kidney disease Obstructive uropathy
123
Examples of Vascular diseases that cause HTN
Renal artery stenosis Coarctation of the aorta
124
Examples of Endocrine diseases that cause HTN
Primary hyperaldosteronism Phaeochromocytoma Cushing’s syndrome Acromegaly Hypothyroidism Hyperthyroidism
125
Examples of Drugs that cause HTN
Combined oral contraceptive pill Corticosteroids Non-steroidal anti-inflammatories (NSAIDs) Venlafaxine Alcohol Illicit drugs (e.g. cocaine)
126
Risk Factors for developing HTN
Sex: up to 65 years women tend to have lower blood pressures than men, however, between the ages of 65-74 years women tend to have higher blood pressures. Ethnicity: people of Black African and Black Caribbean origin are at a higher risk of developing HTN. Age: blood pressure rises with increasing age. Lifestyle factors: cigarette smoking, excess alcohol consumption, excess dietary salt intake, obesity and lack of physical activity.
127
Red Flag Symptoms of accelerated or malignant HTN
Headache Visual disturbances Seizures Nausea and vomiting Chest pain
128
Symptoms suggestive of kidney disease as a secondary cause of HTN include:
Haematuria ‘Frothy’ urine suggestive of proteinuria Dyspnoea (pulmonary oedema) Lower limb swelling (peripheral oedema) Flank tenderness and pain Weight loss is suggestive of renal cell carcinoma
129
Symptoms suggestive of coarctation of the aorta as a secondary cause of HTN include:
Headache Epistaxis Intermittent claudication Lower limb weakness Cold legs and feet
130
Symptoms suggestive of endocrine disease as a secondary cause of HTN include:
Muscle weakness, muscle spasms and paraesthesia are suggestive of hyperaldosteronism. Severe headache, palpitations and sweating are suggestive of phaeochromocytoma. Weight gain particularly abdominal, facial and on the back of the neck and shoulders is suggestive of Cushing’s syndrome. Tall statures, swelling of the hands and feet and deepening of the voice are suggestive of acromegaly. Weight gain, cold intolerance and low mood are suggestive of hypothyroidism. Weight loss, heat intolerance and palpitations are suggestive of hyperthyroidism.
131
Typical clinical findings in secondary causes of HTN include:
Autosomal dominant polycystic kidney disease: enlarged palpable kidneys when balloting the kidneys. Renal artery stenosis: renal bruits heard when auscultating over the area of the renal arteries. Coarctation of the aorta: systolic murmur in the left infraclavicular region under the left scapula and radio-femoral delay. Cushing’s syndrome: moon facies, abdominal purple striae and bruising. Hypothyroidism: brittle nails, dry skin and thin hair. Hyperthyroidism: fine tremor, palmar erythema and a neck goitre.
132
Complications of HTN
Ischaemic heart disease (angina and acute coronary syndrome) Cerebrovascular accident (stroke or intracranial haemorrhage) Vascular disease (peripheral arterial disease, aortic dissection and aortic aneurysms) Hypertensive retinopathy Hypertensive nephropathy Vascular dementia Left ventricular hypertrophy Heart failure
133
NICE recommend measuring blood pressure every _ years to screen for hypertension. It should be measured more often in borderline cases and every year in patients with type 2 diabetes.
5
134
What should you use to confirm dx of HTN?
Patients with a clinic blood pressure between 140/90 mmHg and 180/120 mmHg should have 24-hour ambulatory blood pressure or home readings to confirm the diagnosis. Having blood pressure taken by a doctor or nurse often results in a higher reading. This is commonly called “white coat syndrome”. The white coat effect involves more than a 20/10 mmHg difference in blood pressure between clinic and ambulatory or home readings.
135
Which arm do you take BP readings from?
NICE recommend measuring blood pressure in both arms, and if the difference is more than 15 mmHg, using the reading from the arm with the higher pressure.
136
Clinic Reading and Confirmed Ambulatory/Home Reading for Stage 1 HTN
Clinic Reading : > 140/90 Ambulatory/Home Reading : > 135/85
137
Clinic Reading and Confirmed Ambulatory/Home Reading for Stage 2 HTN
Clinic Reading : > 160/100 Ambulatory/Home Reading : > 150/95
138
Clinic Reading for Stage 3 HTN
Clinic Reading : > 180/120
139
NICE recommend all patients with a new diagnosis of HTN should have:
Urine albumin:creatinine ratio for proteinuria and dipstick for microscopic haematuria to assess for kidney damage Bloods for HbA1c, renal function and lipids Fundus examination for hypertensive retinopathy ECG for cardiac abnormalities, including left ventricular hypertrophy
140
With patients, who have a new HTN dx, what should you calculate for them (in relation to their hearts in the next 10 years), and what should you do about that?
NICE recommend calculating the QRISK score, which estimates the percentage risk that a patient will have a stroke or myocardial infarction in the next 10 years. When the result is above 10%, they should be offered a statin, initially atorvastatin 20mg at night.
141
Lifestyle advice for HTN management
healthy diet, stopping smoking, reducing alcohol, caffeine and salt intake and taking regular exercise.
142
Medications used in the management of HTN
A – ACE inhibitor (e.g., ramipril) B – Beta blocker (e.g., bisoprolol) C – Calcium channel blocker (e.g., amlodipine) D – Thiazide-like diuretic (e.g., indapamide) ARB – Angiotensin II receptor blocker (e.g., candesartan)
143
When are ARBs used in HTN Management?
Angiotensin receptor blockers (ARBs) are recommended by NICE instead of ACE inhibitors in patients of Black African or African-Caribbean family origin. (Can replace ACEi) ARBs are an alternative if the person does not tolerate ACE inhibitors (commonly due to a dry cough). ACE inhibitors and ARBs are not used together.
144
When are Thiazide-like diuretics used in HTN Management?
Thiazide-like diuretics are used as an alternative if the patient does not tolerate calcium channel blockers (commonly due to ankle oedema).
145
Step 1 HTN Management : patient is <55y/o or T2DM of any age or family origin
ACEi e.g. Ramipril or ARB e.g. Losartan
146
Step 1 HTN Management : patient is >55y/o or Black African
Calcium Channel Blocker e.g. amlodipine
147
Step 2 HTN Managament : patient is <55y/o or T2DM of any age or family origin
ACEi/ARB + CCB
148
Step 2 HTN Managament :patient is <55y/o or T2DM of any age or family origin + patient does not tolerate CCBs
ACEi/ARBs + thiazide-like Diuretics e.g Indapamide
149
Step 2 HTN Managament : patient is >55y/o or Black African
CCBs + thiazide-like Diuretics or ACEi/ARBs
150
Step 3 HTN Management
ACEi/ ARBs + CCBs + thiazide-like Diuretics
151
Step 4 HTN Management : patients [K+] ≤ 4.5 mmol/L
ACEi/ ARBs + CCBs + thiazide-like Diuretics + Spironolactone
152
Step 4 HTN Management : patients [K+] > 4.5 mmol/L
ACEi/ ARBs + CCBs + thiazide-like Diuretics + Doxazocin/ Atenolol
153
What does Step 4 HTN management depend on?
Step 4 depends on the serum potassium level: Less than or equal to 4.5 mmol/L consider a potassium-sparing diuretic, such as spironolactone More than 4.5 mmol/L consider an alpha blocker (e.g., doxazosin) or a beta blocker (e.g., atenolol)
154
How does Spironolactone work?
Spironolactone is a potassium-sparing diuretic. It works by blocking the action of aldosterone in the kidneys, resulting in sodium excretion and potassium reabsorption. It can be helpful when thiazide diuretics are causing hypokalaemia.
155
Using Spironolactone increases the risk of ___kalaemia
hyper
156
ACEi can cause ___kalemia
hyper
157
Treatment targets for patient w/ HTN <80 y/o
Systolic : <140 Diastolic : < 90
158
Treatment targets for patient w/ HTN >80 y/o
Systolic : < 150 Diastolic : > 90
159
What is accelated HTN / Malignant HTN?
refers to extremely high blood pressure, above 180/120, with retinal haemorrhages or papilloedema.
160
Management of patients with Malignant HTN?
The NICE guidelines recommend a same-day referral for patients with accelerated hypertension. Therefore, patients with a blood pressure above 180/120 require a fundoscopy examination to look for these key findings. Additional complications also warrant same-day assessment, such as confusion, heart failure, suspected acute coronary syndrome or acute kidney injury. Patients admitted with a hypertensive emergency are assessed for secondary causes and end-organ damage. Their blood pressure is closely monitored while medications bring it under control.
161
IV options for Hypertensive emergency
Sodium nitroprusside Labetalol Glyceryl trinitrate Nicardipine
162
MoA of ACEi
Inhibit the conversion angiotensin I to angiotensin II
163
SE of ACEi
Cough Angioedema Hyperkalaemia
164
MoA of CCB
Block voltage-gated calcium channels relaxing vascular smooth muscle and force of myocardial contraction
165
SE of CCB
Flushing Ankle swelling Headache
166
MoA of Thiazide-like Diuretics
Inhibit sodium absorption at the beginning of the distal convoluted tubule
167
SE of Thiazide-like Diuretics
Hyponatraemia Hypokalaemia Dehydration
168
MoA of ARBs
Block effects of angiotensin II at the AT1 receptor
169
SE of ARBs
Hyperkalaemia
170
What is Peripheral Arterial Disease (PAD)?
Peripheral arterial disease (PAD) refers to the narrowing of the arteries supplying the limbs and periphery, reducing the blood supply to these areas. It usually refers to the lower limbs, resulting in symptoms of claudication.
171
What is Intermittent Claudication?
Intermittent claudication is a symptom of ischaemia in a limb, occurring during exertion and relieved by rest. It is typically a crampy, achy pain in the calf, thigh or buttock muscles associated with muscle fatigue when walking beyond a certain intensity.
172
What is Chronic Limb-threatening Ischaemia?
Chronic limb-threatening ischaemia (previously critical limb ischaemia) is the end-stage of peripheral arterial disease, where there is an inadequate supply of blood to a limb to allow it to function normally at rest. There is a significant risk of losing the limb.. The features are pain at rest, non-healing ulcers and gangrene. Critical limb ischaemia typically causes burning pain that is worse at night when the leg is raised, as gravity no longer helps pull blood into the foot.
173
What is acute limb ischaemia?
Acute limb ischaemia refers to a rapid onset of ischaemia in a limb. Typically, this is due to a thrombus (clot) blocking the arterial supply of a distal limb, similar to a thrombus blocking a coronary artery in myocardial infarction.
174
What is Ischaemia?
Ischaemia refers to an inadequate oxygen supply to the tissues due to reduced blood supply.
175
What is Necrosis?
Necrosis refers to the death of tissue.
176
What is Gangrene?
Gangrene refers to the death of the tissue, specifically due to an inadequate blood supply.
177
What is Atherosclerosis?
Athero- refers to soft or porridge-like and -sclerosis refers to hardening. Atherosclerosis is a combination of atheromas (fatty deposits in the artery walls) and sclerosis (the process of hardening or stiffening of the blood vessel walls). Atherosclerosis affects the medium and large arteries. It is caused by chronic inflammation and activation of the immune system in the artery wall. Lipids are deposited in the artery wall, followed by the development of fibrous atheromatous plaques.
178
What do atherosclerotic plaques cause?
Stiffening of the artery walls, leading to hypertension (raised blood pressure) and strain on the heart (whilst trying to pump blood against increased resistance) Stenosis, leading to reduced blood flow (e.g., in angina) Plaque rupture, resulting in a thrombus that can block a distal vessel and cause ischaemia (e.g., in acute coronary syndrome)
179
Non-modifiable risk factors for atherosclerosis?
Older age Family history Male
180
Modifiable risk factors for atherosclerosis?
Smoking Alcohol consumption Poor diet (high in sugar and trans-fat and low in fruit, vegetables and omega 3s) Low exercise / sedentary lifestyle Obesity Poor sleep Stress
181
Medical co-morbidities increase the risk of atherosclerosis and should be carefully managed to minimise the risk:
Diabetes Hypertension Chronic kidney disease Inflammatory conditions such as rheumatoid arthritis Atypical antipsychotic medications
182
Complications of atherosclerosis
Angina Myocardial infarction Transient ischaemic attack Stroke Peripheral arterial disease Chronic mesenteric ischaemia
183
The features of acute limb ischaemia can be remembered with the “6 P’s” mnemonic
Pain Pallor Pulseless Paralysis Paraesthesia (abnormal sensation or “pins and needles”) Perishing cold
184
Leriche Syndrome
Leriche syndrome occurs with occlusion in the distal aorta or proximal common iliac artery. There is a clinical triad of: Thigh/buttock claudication Absent femoral pulses Male impotence
185
Signs of arterial disease on inspection are:
Skin pallor Cyanosis Dependent rubor (a deep red colour when the limb is lower than the rest of the body) Muscle wasting Hair loss Ulcers Poor wound healing Gangrene (breakdown of skin and a dark red/black change in colouration)
186
Examination signs of PAD
Reduced skin temperature Reduce sensation Prolonged capillary refill time (more than 2 seconds) Changes during Buerger’s test
187
Explain Buerger's Test
Buerger’s test is used to assess for peripheral arterial disease in the leg. There are two parts to the test. The first part involves the patient lying on their back (supine). Lift the patient’s legs to an angle of 45 degrees at the hip. Hold them there for 1-2 minutes, looking for pallor. Pallor indicates the arterial supply is not adequate to overcome gravity, suggesting peripheral arterial disease. Buerger’s angle refers to the angle at which the leg is pale due to inadequate blood supply. For example, a Buerger’s angle of 30 degrees means that the legs go pale when lifted to 30 degrees. The second part involves sitting the patient up with their legs hanging over the side of the bed. Blood will flow back into the legs assisted by gravity. In a healthy patient, the legs will remain a normal pink colour. In a patient with peripheral arterial disease, they will go: Blue initially, as the ischaemic tissue deoxygenates the blood Dark red after a short time, due to vasodilation in response to the waste products of anaerobic respiration The dark red colour is referred to as rubor.
188
Causes of arterial ulcers
Arterial ulcers are caused by ischaemia secondary to an inadequate blood supply
189
Typical features of arterial ulcers
Are smaller than venous ulcers Are deeper than venous ulcers Have well defined borders Have a “punched-out” appearance Occur peripherally (e.g., on the toes) Have reduced bleeding Are painful
190
Causes of venous ulcers
Venous ulcers are caused by impaired drainage and pooling of blood in the legs.
191
Typical features of venous ulcers
Occur after a minor injury to the leg Are larger than arterial ulcers Are more superficial than arterial ulcers Have irregular, gently sloping borders Affect the gaiter area of the leg (from the mid-calf down to the ankle) Are less painful than arterial ulcers Occur with other signs of chronic venous insufficiency (e.g., haemosiderin staining and venous eczema)
192
Ix for PAD
Ankle-brachial pressure index (ABPI) Duplex ultrasound – ultrasound that shows the speed and volume of blood flow Angiography (CT or MRI) – using contrast to highlight the arterial circulation
193
What is ABPI ?
Ankle-brachial pressure index (ABPI) is the ratio of systolic blood pressure (SBP) in the ankle (around the lower calf) compared with the systolic blood pressure in the arm. These readings are taken manually using a Doppler probe. For example, an ankle SBP of 80 and an arm SBP of 100 gives a ratio of 0.8 (80/100). Interpretation (as per NICE CKS 2024): 1.0 – 1.4: normal 0.9 – 0.99: possible peripheral arterial disease Less than 0.9: suggests peripheral arterial disease Less than 0.5: suggests severe and limb-threatening ischaemic
194
An ABPI above ___ can indicate calcification of the arteries, making them difficult to compress. This is more common in diabetic patients.
1.3
195
Lifestyle management of PAD
Lifestyle changes are required to manage modifiable risk factors (e.g., stop smoking). Optimise medical treatment of co-morbidities (such as hypertension and diabetes). Exercise training, involving a structured and supervised program of regularly walking to the point of near-maximal claudication and pain, then resting and repeating.
196
Medical management of PAD
Atorvastatin 80mg Clopidogrel 75mg once daily (aspirin if clopidogrel is unsuitable) Naftidrofuryl oxalate (5-HT2 receptor antagonist that acts as a peripheral vasodilator)
197
Surgical management of PAD
Endovascular angioplasty and stenting Endarterectomy – cutting the vessel open and removing the atheromatous plaque Bypass surgery – using a graft to bypass the blockage Endovascular angioplasty and stenting involve inserting a catheter through the arterial system under x-ray guidance. At the site of the stenosis, a balloon is inflated to create space in the lumen. A stent is inserted to keep the artery open. Endovascular treatments have lower risks but might not be suitable for more extensive disease.
198
Management of Critcal Limb Ischaemia
Patients with critical limb ischaemia require urgent referral to the vascular team. They require analgesia to manage the pain. Urgent revascularisation can be achieved by: Endovascular angioplasty and stenting Endarterectomy Bypass surgery Amputation of the limb if it is not possible to restore the blood supply
199
Management of Acute Limb Ischaemia
Patients with acute limb ischaemia need an urgent referral to the on-call vascular team for assessment. Management options include: Endovascular thrombolysis – inserting a catheter through the arterial system to apply thrombolysis directly into the clot Endovascular thrombectomy – inserting a catheter through the arterial system and removing the thrombus by aspiration or mechanical devices Surgical thrombectomy – cutting open the vessel and removing the thrombus Endarterectomy Bypass surgery Amputation of the limb if it is not possible to restore the blood supply
200
What are varicose veins ?
Varicose veins are distended superficial veins measuring more than 3mm in diameter, usually affecting the legs.
201
What are Reticular veins?
Reticular veins are dilated blood vessels in the skin measuring less than 1-3mm in diameter.
202
What is Telangiectasia?
Telangiectasia refers to dilated blood vessels in the skin measuring less than 1mm in diameter. They are also known as spider veins or thread veins.
203
How do varicose veins develop?
Veins contain valves that only allow blood to flow in one direction, towards the heart. In the legs, as the muscles contract, they squeeze blood upwards against gravity. The valves prevent gravity from pulling the blood back into the feet. When the valves become incompetent, the blood is drawn downwards by gravity and pools in the veins and feet. The deep and superficial veins are connected by vessels called the perforating veins (or perforators), which allow blood to flow from the superficial veins to the deep veins. When the valves are incompetent in these perforators, blood flows from the deep veins back into the superficial veins and overloads them. This leads to dilatation and engorgement of the superficial veins, forming varicose veins.
204
How does venous eczema happen?
When blood pools in the distal veins, the pressure causes the veins to leak small amounts of blood into the nearby tissues. The haemoglobin in this leaked blood breaks down to haemosiderin, which is deposited around the shins in the legs. This gives a brown discolouration to the lower legs. Pooling of blood in the distal tissues results in inflammation. The skin becomes dry and inflamed, referred to as venous eczema.
205
What is lipodermatosclerosis?
The skin and soft tissues become fibrotic and tight, causing the lower legs to become narrow and hard, referred to as lipodermatosclerosis.
206
Risk factors for varicose veins
Increasing age Family history Female Pregnancy Obesity Prolonged standing (e.g., occupations involving standing for long periods) Deep vein thrombosis (causing damage to the valves)
207
Presentation for varicose veins
Varicose veins present with engorged and dilated superficial leg veins. They may be asymptomatic or have symptoms of: Heavy or dragging sensation in the legs Aching Itching Burning Oedema Muscle cramps Restless legs Patients may also have signs and symptoms of chronic venous insufficiency (e.g., skin changes and ulcers).
208
What is the tap test for varicose veins?
apply pressure to the saphenofemoral junction (SFJ) and tap the distal varicose vein, feeling for a thrill at the SFJ. A thrill suggests incompetent valves between the varicose vein and the SFJ.
209
What is the cough test for varicose veins?
apply pressure to the SFJ and ask the patient to cough, feeling for thrills at the SFJ. A thrill suggests a dilated vein at the SFJ (called saphenous varix).
210
What is the Trendelenburg's test for varicose veins?
with the patient lying down, lift the affected leg to drain the veins completely. Then apply a tourniquet to the thigh and stand the patient up. The tourniquet should prevent the varicose veins from reappearing if it is placed distally to the incompetent valve. If the varicose veins appear, the incompetent valve is below the level of the tourniquet. Repeat the test with the tourniquet at different levels to assess the location of the incompetent valves.
211
What is the Perthes Test for varicose veins?
apply a tourniquet to the thigh and ask the patient to pump their calf muscles by performing heel raises whilst standing. If the superficial veins disappear, the deep veins are functioning. Increased dilation of the superficial veins indicates a problem in the deep veins, such as deep vein thrombosis.
212
How is duplex US used for varicose veins?
Duplex ultrasound can be used to assess the extent of varicose veins. It is an ultrasound that shows the speed and volume of blood flow.
213
Simple managment of varicose veins?
Varicose veins in pregnancy often improve after delivery. Simple treatment measures include: Weight loss if appropriate Staying physically active Keeping the leg elevated when possible to help drainage Compression stockings (exclude arterial disease first with an ankle-brachial pressure index)
214
Surgical options for varicose veins
Endothermal ablation – inserting a catheter into the vein to apply radiofrequency ablation Sclerotherapy – injecting the vein with an irritant foam that causes closure of the vein Stripping – the veins are ligated and pulled out of the leg
215
Complications of varicose veins
Prolonged and heavy bleeding after trauma Superficial thrombophlebitis (thrombosis and inflammation in the superficial veins) Deep vein thrombosis All the issues of chronic venous insufficiency (e.g., skin changes and ulcers)
216
What is Syncope?
Syncope is the term used to describe the event of temporarily losing consciousness due to a disruption of blood flow to the brain, often leading to a fall. Syncopal episodes are also known as vasovagal episodes, or simply fainting.
217
What is a Vasovagal Episode?
A vasovagal episode (or attack) is caused by a problem with the autonomic nervous system regulating blood flow to the brain. When the vagus nerve receives a strong stimulus, such as an emotional event, painful sensation or change in temperature it can stimulate the parasympathetic nervous system. Parasympathetic activation counteracts the sympathetic nervous system, which keeps the smooth muscles in blood vessels constricted. As the blood vessels delivering blood to the brain relax, the blood pressure in the cerebral circulation drops, leading to hypoperfusion of brain tissue. This causes the patient to lose consciousness and “faint”.
218
What is "prodrome"?
Patients often remember the event and can recall how they felt prior to fainting. This is called the prodrome, and involves feeling: Hot or clammy Sweaty Heavy Dizzy or lightheaded Vision going blurry or dark Headache
219
Collateral Hx for a vasovagal episode may sound like...
A collateral history from someone that witnessed the event is essential to get an accurate impression of what happened. During a vasovagal episode they may describe the person: Suddenly losing consciousness and falling to the ground Unconscious on the ground for a few seconds to a minute as blood returns to their brain There may be some twitching, shaking or convulsion activity, which can be confused with a seizure The patient may be a bit groggy following a faint, however this is different from the postictal period that follows a seizure. Postictal patients have a prolonged period of confusion, drowsiness, irritability and disorientation. There may be incontinence with both seizures and syncopal episodes.
220
Primary syncope (simple fainting) causes
Dehydration Missed meals Extended standing in a warm environment, such as a school assembly A vasovagal response to a stimuli, such as sudden surprise, pain or the sight of blood
221
Secondary causes for syncope
Hypoglycaemia Dehydration Anaemia Infection Anaphylaxis Arrhythmias Valvular heart disease Hypertrophic obstructive cardiomyopathy
222
Key features that may be seen with syncope
Prolonged upright position before the event Lightheaded before the event Sweating before the event Blurring or clouding of vision before the event Reduced tone during the episode Return of consciousness shortly after falling No prolonged post-ictal period
223
Key features that may be seen with seizures
Epilepsy aura (smells. tastes or deja vu) before the event Head turning or abnormal limb positions Tonic clonic activity Tongue biting Cyanosis Lasts more than 5 minutes Prolonged post-ictal period
224
Ix for syncope
ECG, particularly assessing for arrhythmia and the QT interval for long QT syndrome 24 hour ECG if paroxysmal arrhythmias are suspected Echocardiogram if structural heart disease is suspected Bloods, including a full blood count (anaemia), electrolytes (arrhythmias and seizures) and blood glucose (diabetes)
225
Advice for simple vasovagal episode
Avoid dehydration Avoid missing meals Avoid standing still for long periods When experiencing prodromal symptoms such as sweating and dizziness, sit or lie down, have some water or something to eat and wait until feeling better